Skip to main content
Harcharan Gill, MD, Urology, Palo Alto, CA, Stanford Health Care

HarcharanGillMD

Urology Palo Alto, CA

Minimally Invasive Surgery, Surgical Oncology

professor

Dr. Gill is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gill's full profile

Already have an account?

Summary

  • Dr. Harcharan Gill is an urologist in Palo Alto, CA and is affiliated with multiple hospitals in the area, including Stanford Health Care and VA Palo Alto Health Care System. He received his medical degree from University of Nairobi College of Health Sciences and has been in practice 40 years. He also speaks multiple languages, including Punjabi. He specializes in minimally invasive surgery and surgical oncology and is experienced in urologic oncology, minimally invasive urologic surgery, urologic trauma and reconstructive surgery, metabolic stone disease, and greenlight laser therapy for benign prostatic hyperplasia.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Urology, 1987 - 1991
  • University of Nairobi College of Health Sciences
    University of Nairobi College of Health SciencesClass of 1977

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1992 - 2026
  • PA State Medical License
    PA State Medical License 1990 - 1992
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Kathryn Simmons Stamey Professorship Endowment 2014
  • America's Top Doctors Castle Connolly, 2002-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Surgical Outcomes and Complications Associated with Presurgical Tyrosine Kinase Inhibition for Advanced Renal Cell Carcinoma (RCC)  
    Harshman LC, Yu RJ, Allen GI, Srinivas S, Gill HS, Chung BI, Urol Oncol, 1/1/2013
  • Long-term Outcomes from a Prospective Trial of Stereotactic Body Radiotherapy for Low-risk Prostate Cancer  
    King CR, Brooks JD, Gill H, Presti JC, Int J Radiat Oncol Biol Phys, 1/1/2012
  • Prostate Specific Antigen: The Past, Present and Future  
    Gill H, Wu J, Curr Urol, 1/1/2012
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Review on BPH, Plenary Session 
    San Francisco - 1/1/2014
  • Take Home Messages in Testes and Penile Cancer 
    San Diego - 1/1/2013
  • Highlighs on Penile and Bladder Cancer Plenary Session 
    San Diego - 1/1/2013
  • Join now to see all

Other

  • Primary Care Update in Urology 
    Gill, H.S., Monographs in Urology, American Urologic Association
    1/1/2010

Professional Memberships

Other Languages

  • Punjabi

Hospital Affiliations